tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Impact BioMedical Converts Preferred Stock to Common

Story Highlights
Impact BioMedical Converts Preferred Stock to Common

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

Impact BioMedical, Inc. ( (IBO) ) has shared an update.

On October 30, 2023, Impact BioMedical, Inc. announced that DSS BioHealth Security, Inc. has converted its Series A Convertible Preferred Stock into 60,496,041 shares of common stock. This conversion could potentially impact the company’s market operations by increasing the number of common shares available, which may influence shareholder value and market perception.

More about Impact BioMedical, Inc.

Average Trading Volume: 219,531

Technical Sentiment Signal: Strong Sell

Find detailed analytics on IBO stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1